Ford I - Search Results

1

Biochemical detection of left-ventricular systolic dysfunction.

McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. McDonagh TA, et al. Among authors: ford i. Lancet. 1998 Jan 3;351(9095):9-13. doi: 10.1016/s0140-6736(97)03034-1. Lancet. 1998. PMID: 9433422

2

Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.

Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, Ford I, McMurray JJ, Dargie HJ. Murdoch DR, et al. Among authors: ford i. Heart. 1997 Dec;78(6):594-7. doi: 10.1136/hrt.78.6.594. Heart. 1997. PMID: 9470878 Free PMC article.

3

Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction.

Oldroyd KG, Pye MP, Ray SG, Christie J, Ford I, Cobbe SM, Dargie HJ. Oldroyd KG, et al. Among authors: ford i. Am J Cardiol. 1991 Sep 15;68(8):713-8. doi: 10.1016/0002-9149(91)90641-w. Am J Cardiol. 1991. PMID: 1892076 Clinical Trial.

4

Early treatment with captopril after acute myocardial infarction.

Ray SG, Pye M, Oldroyd KG, Christie J, Connelly DT, Northridge DB, Ford I, Morton JJ, Dargie HJ, Cobbe SM. Ray SG, et al. Among authors: ford i. Br Heart J. 1993 Mar;69(3):215-22. doi: 10.1136/hrt.69.3.215. Br Heart J. 1993. PMID: 8461219 Free PMC article. Clinical Trial.

5

Mortality in heart failure: clinical variables of prognostic value.

Cleland JG, Dargie HJ, Ford I. Cleland JG, et al. Among authors: ford i. Br Heart J. 1987 Dec;58(6):572-82. doi: 10.1136/hrt.58.6.572. Br Heart J. 1987. PMID: 2447925 Free PMC article.

6

Clinical trials in silent ischaemia: lessons from TIBET.

Dargie HJ, Fox KM, Ford I. Dargie HJ, et al. Among authors: ford i. Arch Mal Coeur Vaiss. 1993 Jun;86 Spec No 3:31-4. Arch Mal Coeur Vaiss. 1993. PMID: 8285824 Clinical Trial.

7

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. McDonagh TA, et al. Among authors: ford i. Lancet. 1997 Sep 20;350(9081):829-33. doi: 10.1016/S0140-6736(97)03033-X. Lancet. 1997. PMID: 9310600

8

Calcium-channel blockers and the clinician.

Dargie HJ, Ford I. Dargie HJ, et al. Among authors: ford i. Lancet. 1996 Aug 24;348(9026):488-9. doi: 10.1016/s0140-6736(05)64663-6. Lancet. 1996. PMID: 8757144 No abstract available.

9

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD. Packard CJ, et al. Among authors: ford i. N Engl J Med. 2000 Oct 19;343(16):1148-55. doi: 10.1056/NEJM200010193431603. N Engl J Med. 2000. PMID: 11036120

10

Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.

Gaw A, Docherty G, Brown EA, Ford I. Gaw A, et al. Among authors: ford i. Atherosclerosis. 1999 Apr;143(2):445-50. doi: 10.1016/s0021-9150(98)00305-0. Atherosclerosis. 1999. PMID: 10217375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results